Late Pulmonary Embolism after COVID-19 Pneumonia despite Adequate Rivaroxaban Treatment

INTRODUCTION: SARS-CoV-2 infection may predispose patients to thrombotic disease. Patients with COVID-19 pneumonia who are receiving non-vitamin K antagonists or direct oral anticoagulants for chronic disease are usually switched to heparin treatment during hospitalization. However, information abou...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Tano, Giuseppe, Moschini, Luigi, Loffi, Marco, Testa, Sophie, Danzi, Gian Battista
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SMC Media Srl 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7350955/
https://www.ncbi.nlm.nih.gov/pubmed/32665940
http://dx.doi.org/10.12890/2020_001790

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7350955/
https://www.ncbi.nlm.nih.gov/pubmed/32665940
http://dx.doi.org/10.12890/2020_001790

Ejemplares similares